Metraipolis › archive › dc_be217c74beaa

Identification of a TOP3A genetic variant as a novel biomarker for sensitivity to doxorubicin — Europe PMC PMID:42212268

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42212268
DOI
10.3389/fphar.2026.1724882
License (as archived)
solo-consultazione
Archived
2026-11-02T09:44:48.946Z
SHA-256 of the archived text
affc24d9291bf9dea3133282f34cb148122933fb4f6624e05c67053275e302ae
Stable URL of this page
https://metraipolis.com/documento/dc_be217c74beaa

How to cite

Identification of a TOP3A genetic variant as a novel biomarker for sensitivity to doxorubicin — Europe PMC PMID:42212268 — Europe PMC (en), https://europepmc.org/article/MED/42212268 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_be217c74beaa (Metraipolis archive dc_be217c74beaa, sha256 affc24d9291bf9dea3133282f34cb148122933fb4f6624e05c67053275e302ae)
BibTeX
@misc{dcbe217c74beaa,
  title = {Identification of a TOP3A genetic variant as a novel biomarker for sensitivity to doxorubicin — Europe PMC PMID:42212268},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42212268},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_be217c74beaa; sha256 affc24d9291bf9dea3133282f34cb148122933fb4f6624e05c67053275e302ae},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42212268. Agents can read the archived copy with the MCP tool read_document.